Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition)

Lin Yao; Yicong Du; Wen Dong; Xianshu Gao; Jun Guo; Jianxing Qiu; Qiang Wei; Shikai Wu; Dingwei Ye; Wei Yu; Hao Zeng; Qian Zhang; Yong Zhang; Zhiling Zhang; Fangjian Zhou; Wenjing Yang; Hui Wang; Xu Zhang; Zhisong He

Journal of the National Cancer Center (Mar 2024)

Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition)

Lin Yao,
Yicong Du,
Wen Dong,
Xianshu Gao,
Jun Guo,
Jianxing Qiu,
Qiang Wei,
Shikai Wu,
Dingwei Ye,
Wei Yu,
Hao Zeng,
Qian Zhang,
Yong Zhang,
Zhiling Zhang,
Fangjian Zhou,
Wenjing Yang,
Hui Wang,
Xu Zhang,
Zhisong He

Affiliations

Lin Yao: Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China
Yicong Du: Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China
Wen Dong: Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
Xianshu Gao: Department of Radiation Oncology, Peking University First Hospital, Beijing, China
Jun Guo: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China
Jianxing Qiu: Department of Radiology, Peking University First Hospital, Beijing, China
Qiang Wei: Department of Urology, West China Hospital, Sichuan University, Chengdu, China
Shikai Wu: Department of Oncology, Peking University First Hospital, Beijing, China
Dingwei Ye: Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
Wei Yu: Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China
Hao Zeng: Department of Urology, West China Hospital, Sichuan University, Chengdu, China
Qian Zhang: Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China
Yong Zhang: Department of Urology Surgery, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Zhiling Zhang: Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, China
Fangjian Zhou: Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, China
Wenjing Yang: Office for Cancer Diagnosis and Treatment Quality Control, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Hui Wang: Office for Cancer Diagnosis and Treatment Quality Control, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Xu Zhang: Department of Urology, The Third Medical Center, Chinese People Liberation Army (PLA) General Hospital, Beijing, China
Zhisong He: Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China; Corresponding author.

Journal volume & issue: Vol. 4, no. 1
pp. 6 – 13

Abstract

Read online

Renal cancer is one of the most common malignancies of the urinary system, and the number of deaths continues to increase. The standardized management of the diagnosis and treatment of renal cancer is challenging due to the great differences in the diagnosis and treatment of renal cancer in different regions. The Renal Cancer Expert Committee of the National Cancer Quality Control Center (NCQCC) identified a lack of authoritative quality control standards as an opportunity to utilize its multidisciplinary membership to improve the standardized diagnosis and treatment of renal cancer. The Renal Cancer Expert Committee of the NCQCC aims to promote quality control and national standardization, uniformity, and normalization of renal cancer diagnosis and treatment, which ultimately improved the survival rate and quality of life of renal cancer patients. A panel of experts with renal cancer surgery, renal cancer medicine, medical imaging, pathology and radiotherapy were drawn together and determined the quality control standards for the standardized diagnosis and treatment of renal cancer. The Indices includes 20 items that cover all key areas in the diagnosis and treatment of renal cancer, such as standard diagnosis, surgery treatment, systemic treatment, and prognostic evaluation.

Published in Journal of the National Cancer Center

ISSN: 2667-0054 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/journal-of-the-national-cancer-center

About the journal

Abstract

Keywords